Hypermarcas S/A ADR | Income Statement

Fiscal year is January-December. All values BRL Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,259
2,768
2,957
3,228
3,638
3,724
Cost of Goods Sold (COGS) incl. D&A
1,562
713
793
879
955
1,097
Gross Income
2,697
2,055
2,163
2,349
2,683
2,627
SG&A Expense
1,752
1,208
1,260
1,326
1,520
1,443
EBIT
945
-
903
-
1,151
1,167
Unusual Expense
-
47
31
-
-
-
Non Operating Income/Expense
303
129
141
184
37
19
Interest Expense
484
444
559
247
70
48
Pretax Income
315
406
371
833
1,210
1,224
Income Tax
55
67
23
188
102
94
Equity in Affiliates
1
1
3
3
3
5
Consolidated Net Income
259
338
345
647
1,111
1,135
Net Income
259
338
345
647
1,111
1,135
Net Income After Extraordinaries
261
273
131
117
1,258
1,141
Net Income Available to Common
257
403
560
112
1,176
1,141
EPS (Basic)
0.41
0.64
0.89
1.87
1.53
1.79
Basic Shares Outstanding
629
632
632
631
631
632
EPS (Diluted)
0.40
0.63
0.87
1.84
1.52
1.77
Diluted Shares Outstanding
645
644
644
642
636
639
EBITDA
1,043
910
966
1,066
1,219
1,252
Other Operating Expense
-
-
-
21
13
17
Non-Operating Interest Income
157
180
199
262
167
86

About Hypermarcas

View Profile
Address
Rua Nova Cidade, Nº 404
São Paulo Sao Paulo 04547
Brazil
Employees -
Website http://www.hyperapharma.com.br
Updated 07/08/2019
Hypera SA is a pharmaceutical company which manufactures and distributes medical and cosmetics products. It offers business through Prescription Products, Consumer Health, and Similar and Generic segments. The Prescription Products segment deals with therapeutic medicines and dermocosmetics.